/Companies

NeuroOne

Eden Prairie, US · Founded 2016 · Delaware corporation · 1 known investors

Find your way into NeuroOne

Sign up to see every warm intro you have to NeuroOne

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the NeuroOne team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NMTC develops neurotechnology combining medical devices and artificial intelligence, supported by scientific and AI advisory boards. The company works with medical and neuroscience experts to advance its innovations.

Founders & leadership

DRDave Rosa
Dave RosaPresident & Chief Executive OfficerHe has three decades of experience in the medical device industry, including senior roles at C.R. Bard, Boston Scientific, and St. Jude Medical in marketing, product development, and business development; he holds an MBA from Duquesne University and a BS in Commerce and Engineering from Drexel University.
DWDavid Wambecke
David WambeckeChief Business Officer
CVChris Volker
Chris VolkerChief Financial OfficerChris Volker held general management and corporate development roles in medtech, healthcare, and technology companies, with experience in mergers and acquisitions, private equity investments, and strategic partnerships. He has served on boards and in functional leadership across quality, marketing, reimbursement, and human resources.
SMSteve Mertens
Steve MertensChief Technology OfficerSteve Mertens is Chief Technology Officer at NeuroOne, which develops neurotechnology combining medical devices and artificial intelligence. He has experience in research, product development, manufacturing, and commercialization across startup and large-company environments.
EJEmily Johns
Emily JohnsChief Administrative Officer & General Counsel
CDCamilo Diaz-Botia
Camilo Diaz-BotiaVice President of EngineeringCamilo Diaz-Botia brings seven years of neural engineering experience focused on implantable medical devices, with expertise in microfabrication design and integrated systems development. He is Vice President of Engineering at NeuroOne, a neurotechnology company combining medical devices and artificial intelligence.
MCMark Christianson
Mark ChristiansonCo-Founder, VP of Business DevelopmentServes as VP of Business Development at the company he co-founded in 2016. His earlier career includes North American technical sales management at Cortec Corporation, business development at Robert Half Technology, and a regional medical device sales role at PMT Corporation.
WF
Wade FredricksonNamed on SEC filing
SK
Suraj KaliaNamed on SEC filing
JMJeff Mathiesen
Jeff MathiesenNamed on SEC filing
PBPaul Buckman
Paul BuckmanNamed on SEC filing
TB
Thomas BachinskiNamed on SEC filing

Investors · 1

FundRxreportedPalo Alto

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$1.5M disclosed across 1 round · 2016

▶$1.5MraisedJun 2017 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark ChristiansonExecutive Officer
  • Wade FredricksonExecutive Officer
  • Suraj KaliaDirector
  • Jeff MathiesenDirector
  • Paul BuckmanDirector
  • Thomas BachinskiExecutive Officer
  • David A RosaExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$1.5M
Minimum investment
$50K
Sales commissions
$120K
Placement agents
Corinthian Partners, L.L.C.
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
NeuroelectricsNeuroelectrics develops the Starstim platform, combining EEG monitoring headpieces, cloud-based delivery, and personalized protocols to deliver non-invasive Transcranial Electrical Stimulation (tES) neuromodulation therapy for brain disorders such as depression and epilepsy. It serves patients whose conditions are not controlled by drugs or surgery, as well as neuroscience researchers who use its tools for brain research.
NeuroPaceNeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

Companies working in the same space as NeuroOne.

In the news

Frequently asked questions

What does NeuroOne do?
NMTC develops neurotechnology combining medical devices and artificial intelligence, supported by scientific and AI advisory boards. The company works with medical and neuroscience experts to advance its innovations.
Who are NeuroOne's investors?
NeuroOne's investors include FundRx.
How much funding has NeuroOne raised?
NeuroOne has disclosed $1.5M raised across 1 round.
Where is NeuroOne headquartered?
NeuroOne is headquartered in Eden Prairie, US.